|
Living Medical Textbook From Projects In Knowledge |
|
| Chapter 1 Multiple Sclerosis Basics Release date: September 2009 |
||
| Chapter 2 Standard-of-Care Treatment of Multiple Sclerosis Release date: November 2009 |
||
| Chapter 3 Multiple Sclerosis Treatments In Development Release date: December 2009 |
||
|
|
||||||||||
| Chapter 3 – Multiple Sclerosis Treatments In Development | ||||||||||
|
||||||||||
|
Activity Goal The goal of this CME/CE activity is to examine the pathophysiology, etiologic factors, classification, diagnostic criteria, and current and emerging strategies for treating and managing patients with multiple sclerosis. |
||||||||||
|
Target Audience This CME/CE activity is designed for neurologists, internal medicine specialists, family practice/primary care physicians, nurse specialists/nurse practitioners, physician assistants, and other health professionals who interact with and are involved in the management and treatment of patients with multiple sclerosis. |
||||||||||
Learning Objective
|
||||||||||
| top |
||||||||||
|
CME Information: Physicians
Statement of Accreditation Projects In Knowledge® is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Credit Designation Projects In Knowledge designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. CE Information: Nurses Projects In Knowledge® (PIK) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Projects In Knowledge is also an approved provider by the California Board of Registered Nursing, Provider Number CEP-15227. This activity is approved for 1.22 nursing contact hour(s). DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, CBRN, or PIK endorsement of any commercial product or service. CE Information: Pharmacists  Projects In Knowledge® is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program has been planned and implemented in accordance with the ACPE Criteria for Quality and Interpretive Guidelines. This chapter is worth up to 2.00 contact hours (0.2 CEUs). The ACPE Universal Program Number assigned to this knowledge activity is 0052-0000-09-253-H01-P. top |
||||||||||
|
Disclosure Information The Disclosure Policy of Projects In Knowledge requires that presenters comply with the Standards for Commercial Support. All faculty are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed in the course materials. For complete prescribing information on the products discussed during this CME/CE activity, please see your current Physicians' Desk Reference (PDR). Clyde E. Markowitz, MD, Clyde E. Markowitz, MD, has received honoraria from Bayer, Biogen Idec, and Teva Neuroscience; is a consultant for Bayer, Genentech Inc, Biogen Idec, BioMS Medical, Eli Lilly and Company, EMD Serono, Novartis Pharmaceuticals Corporation and Teva Neuroscience. Lauren A. Cerruto has no significant relationships to disclose. This activity includes a discussion of the following therapies: fingolimod, cladribine, laquinimod, dimethyl fumarate, teriflunomide, alemtuzumab, rituximab, ocrelizumab, and daclizumab, all of which are investigational or off-label in the treatment of MS. Peer Reviewer has disclosed no significant relationships. Projects In Knowledge’s staff members have no significant relationships to disclose. top |
||||||||||
Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process. The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge. This CME/CE activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.
|
||||||||||
|
||||||||||
|
|
|
This independent CME/CE activity is supported by an educational grant from Teva Neuroscience. |
|
|
Release Date: December 23, 2009. Termination Date: December 22, 2010. |
|
Estimated time for completion of this activity: CME: 2.0 hours CE: 1.22 hours CPE: 2.0 hours |
|
CME/CE Instructions To obtain CME/CE credit for this activity:
There is no fee for this activity. |
|
